Amendment #98 to S3141

Capping the Price of Epinephrine

Ms. Decker of Cambridge moves to amend the bill by adding the following sections:

"SECTION XX. Subsection (b) of section 26 of chapter 342 of the Acts of 2024, is hereby amended by inserting after the word “members”, the following words:- ; and the following acute condition (i) anaphylaxis.

SECTION XX. Subsection (c) of said section 26 of said chapter 342, as so appearing, is hereby amended by inserting after the word “diabetes”, the following words:- and epinephrine delivered via an autoinjector as the drug used to treat anaphylaxis.

SECTION XX. Said subsection (c) of said section 26 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Said clause (v) of said subsection (c) of said section 26 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Subsection (d) of said section 26 of said chapter 342, as so appearing, is hereby amended by adding the following sentence:- Coverage for 1 brand name of epinephrine delivered via an autoinjector or 1 generic brand of epinephrine delivered via an autoinjector shall not be subject to any deductible or co-insurance and any co-payment shall not exceed $60 for a two-pack of epinephrine autoinjectors.

SECTION XX. Subsection (b) of section 28 of chapter 342 of the Acts of 2024, is hereby amended by inserting after the word “enrollees”, the following words:- ; and the following acute condition (i) anaphylaxis.

SECTION XX. Subsection (c) of said section 28 of said chapter 342, as so appearing, is hereby amended by inserting after the word “diabetes”, the following words:- and epinephrine delivered via an autoinjector as the drug used to treat anaphylaxis.

SECTION XX. Said subsection (c) of said section 28 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Said clause (v) of said subsection (c) of said section 28 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Subsection (d) of said section 28 of said chapter 342, as so appearing, is hereby amended by adding the following sentence:- Coverage for 1 brand name of epinephrine delivered via an autoinjector or 1 generic brand of epinephrine delivered via an autoinjector shall not be subject to any deductible or co-insurance and any co-payment shall not exceed $60 for a two-pack of epinephrine autoinjectors.

SECTION XX. Subsection (b) of section 31 of chapter 342 of the Acts of 2024, is hereby amended by inserting after the word “enrollees”, the following words:- ; and the following acute condition (i) anaphylaxis.

SECTION XX. Subsection (c) of said section 31 of said chapter 342, as so appearing, is hereby amended by inserting after the word “diabetes”, the following words:- and epinephrine delivered via an autoinjector as the drug used to treat anaphylaxis.

SECTION XX. Said subsection (c) of said section 31 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Said clause (v) of said subsection (c) of said section 31 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Subsection (d) of said section 31 of said chapter 342, as so appearing, is hereby amended by adding the following sentence:- Coverage for 1 brand name of epinephrine delivered via an autoinjector or 1 generic brand of epinephrine delivered via an autoinjector shall not be subject to any deductible or co-insurance and any co-payment shall not exceed $60 for a two-pack of epinephrine autoinjectors.

SECTION XX. Subsection (b) of section 33 of chapter 342 of the Acts of 2024, is hereby amended by inserting after the word “enrollees”, the following words:- ; and the following acute condition (i) anaphylaxis.

SECTION XX. Subsection (c) of said section 33 of said chapter 342, as so appearing, is hereby amended by inserting after the word “diabetes”, the following words:- and epinephrine delivered via an autoinjector as the drug used to treat anaphylaxis.

SECTION XX. Said subsection (c) of said section 33 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Said clause (v) of said subsection (c) of said section 33 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Subsection (d) of said section 33 of said chapter 342, as so appearing, is hereby amended by adding the following sentence:- Coverage for 1 brand name of epinephrine delivered via an autoinjector or 1 generic brand of epinephrine delivered via an autoinjector shall not be subject to any deductible or co-insurance and any co-payment shall not exceed $60 for a two-pack of epinephrine autoinjectors.

SECTION XX. Subsection (b) of section 34 of chapter 342 of the Acts of 2024, is hereby amended by inserting after the word “enrollees”, the following words:- ; and the following acute condition (i) anaphylaxis.

SECTION XX. Subsection (c) of said section 34 of said chapter 342, as so appearing, is hereby amended by inserting after the word “diabetes”, the following words:- and epinephrine delivered via an autoinjector as the drug used to treat anaphylaxis.

SECTION XX. Said subsection (c) of said section 34 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Said clause (v) of said subsection (c) of said section 34 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Subsection (d) of said section 34 of said chapter 342, as so appearing, is hereby amended by adding the following sentence:- Coverage for 1 brand name of epinephrine delivered via an autoinjector or 1 generic brand of epinephrine delivered via an autoinjector shall not be subject to any deductible or co-insurance and any co-payment shall not exceed $60 for a two-pack of epinephrine autoinjectors.

SECTION XX. Subsection (b) of section 35 of chapter 342 of the Acts of 2024, is hereby amended by inserting after the word “enrollees”, the following words:- ; and the following acute condition (i) anaphylaxis.

SECTION XX. Subsection (c) of said section 35 of said chapter 342, as so appearing, is hereby amended by inserting after the word “diabetes”, the following words:- and epinephrine delivered via an autoinjector as the drug used to treat anaphylaxis.

SECTION XX.  Said subsection (c) of said section 35 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Said clause (v) of said subsection (c) of said section 35 of said chapter 342, as so appearing, is hereby further amended by inserting after the word “condition”, the following words:- or acute condition.

SECTION XX. Subsection (d) of said section 35 of said chapter 342, as so appearing, is hereby amended by adding the following sentence:- Coverage for 1 brand name of epinephrine delivered via an autoinjector or 1 generic brand of epinephrine delivered via an autoinjector shall not be subject to any deductible or co-insurance and any co-payment shall not exceed $60 for a two-pack of epinephrine autoinjectors.

SECTION XX. This act shall apply to all contracts entered into, renewed or amended on or after July 1, 2026."


Additional co-sponsor(s) added to Amendment #98 to S3141

Capping the Price of Epinephrine

Representative:

Estela A. Reyes

Colleen M. Garry

David Henry Argosky LeBoeuf